Search hospitals > Pennsylvania > Pittsburgh
Children's Hospital of Pittsburgh of UPMC
Claim this profilePittsburgh, Pennsylvania 15224
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Solid Tumors
Conducts research for Relapse
907 reported clinical trials
83 medical researchers
Summary
Children's Hospital of Pittsburgh of UPMC is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Cancer, Brain Tumor, Adult T-Cell Leukemia/Lymphoma, Solid Tumors, Relapse and other specialties. Children's Hospital of Pittsburgh of UPMC is involved with conducting 907 clinical trials across 1,090 conditions. There are 83 research doctors associated with this hospital, such as Jean M. Tersak, Andrew Bukowinski, Adam Olson, and James Felker, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderBRAF positive
Stage IV
Stage II
Top PIs
Jean M. TersakChildren's Hospital of Pittsburgh of UPMC8 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
43 reported clinical trials
99 drugs studied
Andrew BukowinskiChildren's Hospital of Pittsburgh of UPMC9 years of reported clinical research
Studies Cancer
Studies Relapse
24 reported clinical trials
38 drugs studied
Adam OlsonUPMC-Shadyside Hospital1 year of reported clinical research
Studies Prostatic Neoplasm
Studies Prostate Cancer
17 reported clinical trials
55 drugs studied
James Felker, MDChildren's Hospital of Pittsburgh of UPMC5 years of reported clinical research
Expert in Brain Tumor
Studies Brain Cancer
17 reported clinical trials
29 drugs studied
Clinical Trials running at Children's Hospital of Pittsburgh of UPMC
Cancer
Brain Tumor
Acute Lymphoblastic Leukemia
Wilms Tumor
Lymphoma
Adult T-Cell Leukemia/Lymphoma
Testicular cancer
Acute Leukemia
Brain Cancer
Myelodysplastic Syndrome
Triptorelin
for Cancer
This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with an alkylating agents. Alkylating agents are part of standard chemotherapy, but may cause damage to the ovaries. If the ovaries are not working well or completely shut down, then it will be difficult or impossible to get pregnant in the future. Triptorelin works by blocking certain hormones and causing the ovaries to slow down or pause normal activity. The triptorelin used in this study stays active in the body for 24 weeks or about 6 months after a dose is given. After triptorelin is cleared from the body, the ovaries resume normal activities. Adding triptorelin before the start of chemotherapy treatment may reduce the chances of damage to the ovaries.
Recruiting2 awards Phase 34 criteria
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting2 awards Phase 37 criteria
Various Treatments
for Wilms Tumor
This phase III trial studies using risk factors in determining treatment for children with favorable tissue (histology) Wilms tumors (FHWT). Wilms Tumor is the most common type of kidney cancer in children, and FHWT is the most common subtype. Previous large clinical trials have established treatment plans that are likely to cure most children with FHWT, however some children still have their cancer come back (called relapse) and not all survive. Previous research has identified features of FHWT that are associated with higher or lower risks of relapse. The term "risk" refers to the chance of the cancer coming back after treatment. Using results of tumor histology tests, biology tests, and response to therapy may be able to improve treatment for children with FHWT.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Children's Hospital of Pittsburgh of UPMC?
Where is Children's Hospital of Pittsburgh of UPMC located?
Who should I call to ask about financial aid or insurance network?
What insurance does Children's Hospital of Pittsburgh of UPMC accept?
What awards or recognition has Children's Hospital of Pittsburgh of UPMC received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.